1. Introduction {#sec1}
===============

Recently, laparoscopic surgeries have been widely accepted as a treatment of colon diseases including colon cancer \[[@B1]--[@B3]\]. Most surgeons are convinced by the short time benefit of the laparoscopic approach in colorectal surgery, that is, early postoperative recovery, decreased postoperative pain, reduced pulmonary dysfunction, and shorter hospitalization \[[@B4]--[@B6]\]. Moreover, in oncological terms, it has also been shown to be safe in the treatment of colon cancer \[[@B1], [@B2]\]. In order to further improve upon the results of multiport laparoscopic colectomies (LACs), efforts have been made to further reduce the trauma caused by incisions. The rationale for further "scar-less" surgery is that decreasing the number and size of port accesses to the abdominal cavity might be an advantage not only from the cosmetic aspect but also in minimizing the risk of complications such as wound pain and infections as well as incision hernia and internal adhesion formation \[[@B7]\].

The excitement to develop new techniques has given rise to natural orifice transluminal endoscopic surgery (NOTES) \[[@B8]--[@B10]\]. This procedure in both animal \[[@B11]\] and human \[[@B12]\] models has shown some success but certainly has technical challenges: using transgastric, transvaginal, and transrectal access to the abdominal viscera and the need for expensive specialized equipment has hindered the widespread acceptance of this approach. Therefore use of the NOTES approach in performing routine colon resection is far from being practical at this time. Single-incision laparoscopic surgery (SILS) has advantages over NOTES in that existing laparoscopic instruments can be used and relatively minor adjustments from the current multiport laparoscopic technique are needed. The initial applications of SILS in gastrointestinal surgery were cholecystectomy \[[@B13]\], appendectomy \[[@B14]\] and recently, this technique has also been applied to colorectal surgery \[[@B15]--[@B18]\].

In comparison to multiport laparoscopic colectomy, the potential advantages of SILS are thought to be improved cosmesis as well as incisional and/or parietal pain and avoidance of port site-related complications \[[@B19]\]. Since 2008 when single-incision laparoscopic colectomy (SILC) was first introduced, the number of relevant publications has been increasing year by year as shown in [Figure 1](#fig1){ref-type="fig"}. However, because of still limited number of studies reporting SILC \[[@B20]\], its clinical significance remains to be elucidated. The aim of this study is to analyze current literature on SILC and access its potential benefits or efficacy as well as its feasibility and safety.

2. Materials and Methods {#sec2}
========================

2.1. Literature Search Strategies {#sec2.1}
---------------------------------

A systematic search of the scientific literature was carried out using the MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials ClinicalTrials.gov (Available at: <http://clinicaltrials.gov/>), National Research Register, The York (UK) Centre for Reviews, American College of Physicians (ACP) Journal Club, Australian Clinical Trials Registry, relevant online journals, and the Internet for the years 1983--August 2011 to obtain access to all relevant publications, especially randomized controlled trials, systematic reviews, and meta-analyses involving SILC. The search terms were "single-incision," "single port," "single access," "single site," "laparoscopic colectomy," "colectomy," and "laparoscopic colorectal surgery."

2.2. Inclusion and Exclusion Criteria {#sec2.2}
-------------------------------------

Articles were selected if the abstract contained data on patients who underwent SILC for colorectal diseases in the form of RCTs and other controlled or comparative studies. Conference abstracts were included if they contained relevant data. The reference lists of these articles were also reviewed to find additional candidate studies. Searches were conducted without language restriction. To avoid duplication of data, articles from the same unit or hospital were included only once if data was updated in a later publication. However, if surgical cases did not overlap among reports by even the same institute, these reports were all included. Reports with fewer than 10 cases of SILC and review articles were excluded from this study. Data extracted for this study were taken from the published reports; authors were not contacted to obtain additional information. All articles selected for full text review were distributed to 2 reviewers (T.M and S.L.), who independently decided on inclusion/exclusion and independently abstracted the study data. Any discrepancies in agreement were resolved by consensus. The flow chart of this selection process is summarized in [Figure 2](#fig2){ref-type="fig"}.

2.3. Result of the Literature Research {#sec2.3}
--------------------------------------

By using the above search strategy, a total of 249 potentially relevant citations were found. After the exception of 98 duplicated citations, we excluded 86 articles irrelevant of surgical specialty and 37 relevant articles with fewer than 10 cases by reviewing titles and abstracts. 28 publications were selected for review of full text, and 4 studies with no relevant data and 3 review articles were excluded from our paper. Twenty-one studies \[[@B21]--[@B41]\] with a total of 477 patients undergoing SILC met the criteria for analysis providing level 2--4 evidence ([Table 1](#tab1){ref-type="table"}). There were one multi-institutional study and a total of 9 comparative studies including 6 case-matched ones between SILC and other minimally invasive procedures. There were no randomized controlled trials and meta-analyses in the selected literature.

3. Results {#sec3}
==========

3.1. Indications and SILC Procedures {#sec3.1}
------------------------------------

Demographic information and preoperative parameters are shown in [Table 1](#tab1){ref-type="table"}. All studies except 4 performed SILC for colon cancer cases \[[@B23], [@B28], [@B31], [@B40]\]. Among them, 18 studies also included benign colon disease (diverticulitis, Crohn\'s disease, ulcerative colitis, polyps, etc.) \[[@B23], [@B24], [@B26]--[@B41]\]. The most common surgical procedures performed in these series were right hemicolectomy (*n* = 277), followed by sigmoidectomy (*n* = 81). Anterior resections were performed in 5 of 22 studies (*n* = 37). Range of body mass index (BMI) was 21.9--30.0 kg/m^2^ in each study.

3.2. Surgical Instruments and Skin Incision Length {#sec3.2}
--------------------------------------------------

All studies except one \[[@B32]\] used commercially available single port devices as summarized in [Table 3](#tab3){ref-type="table"}. Chen et al. used a surgical glove attached with three trocars for the purpose of reestablishing the pneumoperitoneum after extraction of the specimen and anastomosis \[[@B32]\]. Ross et al., instead of a single access device, used multiple trocars placed through a single skin incision for some patients \[[@B34]\]. All studies, with exception of two \[[@B31], [@B36]\], utilized three ports/trocars (5, 5, 5, or 12 mm) placed through the single access device. Sixteen studies reported on type of laparoscope used \[[@B22]--[@B28], [@B31], [@B32], [@B34]--[@B40]\]. Most of investigators from the studies reported using 30°-angled scopes while two studies used 0° laparoscopes \[[@B22], [@B23]\]. Types of instruments used are detailed in [Table 3](#tab3){ref-type="table"}. The skin incision for the insertion of port systems initially measured 2 to 4 cm, and average length of final scar was 2.7--4.5 cm in 7 studies \[[@B24], [@B25], [@B29], [@B33]--[@B35], [@B38]\] with relevant data. The final (at the end of operation) length of incision scar was longer than the initial one in all 11 studies with available data \[[@B23]--[@B26], [@B29], [@B30], [@B32], [@B35]--[@B38]\].

3.3. Intraoperative Parameters {#sec3.3}
------------------------------

The summary of various operative parameters is shown in [Table 2](#tab2){ref-type="table"}. The range of operative times for SILC procedure was 75--229 minutes (*n* = 21 studies). The range of estimated blood loss was 0--100 mL (*n* = 14 studies). Among all 477 cases eligible in the current paper, a total of 5 cases (1.0%) were converted to open procedures, 3 cases (0.6%) to hand-assisted laparoscopic surgeries (HALS), and 20 cases (4.2%) to conventional (multiport) laparoscopic colectomies (LAC). Overall conversion rate was 5.9% (28/477). Reasons of conversion in these cases were the following: purpose for retraction or aid in colonic mobilization (*n* = 9), severe adhesion (*n* = 4), port trouble (*n* = 3), low-rectal lesions (*n* = 3), obesity (*n* = 3), bleeding (*n* = 1), fistula (*n* = 1), time constrains (*n* = 1), facilitating primary suture closure of colorectal anastomosis following a positive air insufflation test (*n* = 1), T4 tumor (*n* = 1), and unknown reason (*n* = 1). On the other hand, among 15 studies (*n* = 329) with available data, an additional port (adding only one port) was needed during the operation in a total of 16 cases (4.9%; 16/329). No major intraoperative complications were observed in these series.

3.4. Surgical Specimen {#sec3.4}
----------------------

Five studies including right hemicolectomy, sigmoidectomy, and anterior resection showed that the range of specimen lengths was 15--43.5 cm ([Table 4](#tab4){ref-type="table"}) \[[@B22], [@B26], [@B29], [@B30], [@B37]\]. All margins were free of cancer in these series. In 18 studies with available data, the range of number of removed lymph nodes for malignant cases and potential malignant diseases was 12--24.6 ([Table 4](#tab4){ref-type="table"}) \[[@B21], [@B22], [@B24]--[@B27], [@B29], [@B30], [@B32]--[@B41]\].

3.5. Postoperative Parameters {#sec3.5}
-----------------------------

### 3.5.1. Perioperative Mortality {#sec3.5.1}

Overall, 2 perioperative deaths (0.4%; 2/477) were observed. One death, reported by Adair et al., occurred on postoperative day 10, 8 days after discharge from the hospital, due to a pulmonary embolus \[[@B38]\]. Gandhi et al. reported another death, which was encountered in a patient following palliative SILC right hemicolectomy as a result of complications from metastatic disease \[[@B35]\].

### 3.5.2. Morbidity, Reoperation, and Length of Hospital Stay (LOS) {#sec3.5.2}

Postoperative morbidities varied across studies (0--29.4%). Overall 43 patients (11.7%; 43/368) developed complications related to surgery. The most frequent complication was ileus (*n* = 10) and wound infection/hematoma/seroma (*n* = 10) followed by and anastomotic bleeding (*n* = 4) and arrhythmia (*n* = 3). Overall 6 out of 419 patients (1.4%) required reoperation and the reasons in these cases were as follows: anastomotic leakage (*n* = 2), anastomotic bleeding (*n* = 1), wound hematoma (*n* = 1), cecal ischemia with perforation (*n* = 1), and a negative relaparotomy to rule out anastomotic leakage (*n* = 1). In all 21 studies, the range of length of hospital stay (LOS) also varied across reports: 2.7--9.2 days. Notably, 2 studies reported fewer than 3 days of LOS in their series \[[@B35], [@B39]\].

### 3.5.3. Postoperative Anesthesia {#sec3.5.3}

Katsuno et al. reported that analgesics were used 1.4 ± 1.2 times in addition to routinely using the epidural catheter (0.2% ropivacaine hydrochloride hydrate 600 mg plus morphine hydrochloride hydrate 8 mg) for the first 2 to 3 days as postoperative anesthesia and no patients required analgesics after the fourth postoperative day \[[@B25]\]. Wolthuis et al. reported that total consumption of levobupivacaine (313 versus 355 mg) and sufentanyl (250 versus 284 *μ*g) provided by epidural infusion with a patients-controlled bolus capability was similar between SILC and LAC groups (*P* = 0.94) \[[@B26]\]. Chen et al. also found no difference in the postoperative usage of intravenous narcotics (Demerol) between SILC and LAC groups (10 versus 10 mg, *P* = 0.82) \[[@B32]\].

### 3.5.4. Postoperative Recovery of Gastrointestinal Function {#sec3.5.4}

Several reports \[[@B23], [@B25], [@B28], [@B31], [@B32], [@B39], [@B41]\] provided data regarding postoperative recovery of gastrointestinal function; Gash et al. \[[@B39]\], in their analysis of 20 SILC procedures, reported that a normal diet was tolerated in 4--6 hours by 7 patients and in 12--16 hours (overnight) by 11 patients. In 39 SILC cases \[[@B34]\] from multi-institutional studies reviewed, average time to flatus and bowel movement were Days 2.2 and 2.9, respectively, which is supported by 2 other reports (p.o. Day 2-3 of first flatus) \[[@B23], [@B32], [@B42], [@B43]\]. Chen et al., in their case-control study comparing SILS right hemicolectomy to traditional laparoscopic right hemicolectomy, also reported that there was no difference in time until flatus passage (median 2 versus 2 days) \[[@B32]\]. Concerning oral intake after surgeries, Boni et al. \[[@B41]\] reported p.o. Day 2 for first oral fluid intake. In early experience with 31 SILC cases for colon cancer, Katsuno et al. reported that the time to adequate oral intake was 1.5 ± 0.8 days \[[@B25]\].

3.6. Comparative Studies: SILC versus Other Minimally Invasive Surgeries {#sec3.6}
------------------------------------------------------------------------

A total of 9 comparative studies \[[@B21], [@B24], [@B26], [@B29], [@B32], [@B33], [@B35], [@B37], [@B38]\] including 6 case-matched studies \[[@B24], [@B26], [@B29], [@B33], [@B35], [@B38]\] between SILC and other minimally invasive procedures are summarized in Tables [5](#tab5){ref-type="table"} and [6](#tab6){ref-type="table"}. Ramos-Valadez et al., in their case-matched series (SILC versus LAC group), reported that mean estimated blood loss was significantly lower for the SILC group (*n* = 20) compared to the LAC group (*n* = 20) (58 versus 99 mL, *P* \< 0.007) \[[@B24]\]. Champagne et al., in their case-controlled study comparing SILC (*n* = 29) versus laparoscopic-assisted (*n* = 29) segmental colectomy, reported that SILC is feasible and safe but takes longer time in surgery (134 versus 104 min *P* = 0.0002) \[[@B29]\]. There were no short-term outcome benefits associated with SILC. Chen et al. also did not find any significant benefits associated with right hemicolectomy by SILS approach compared to the same procedure by the multiport laparoscopic approach \[[@B32]\]. McNally et al., comparing 27 SILC cases with 46 LAC cases, reported relatively shorter LOS in SILC versus LAC cases (3 versus 5 days) but with no statistical significance (*P* = 0.07). Gandhi et al., comparing 24 case-matched patients undergoing right hemicolectomy or anterior rectosigmoidectomy between SILC and hand-assisted laparoscopic colectomy (HALC), reported that the average operative time was longer in SILC as compared to HALC (143 versus 113 min *P* = 0.0004) while there was no difference in conversion rate or perioperative complications \[[@B35]\]. Importantly, average LOS was significantly shorter in the SILC group compared with the HALC group (2.7 versus 3.3 days *P* \< 0.02), which was also supported by another case-matched study performing right colectomies where Papaconstantinou et al. \[[@B33]\] reported that LOS was significantly shorter in the SILC group (*n* = 29) compared to LAC (*n* = 29) and HALC (*n* = 29) groups (3.4 versus 4.6 versus 4.9 days, *P* \< 0.05). In addition, maximum pain scores on p.o. Days 1 and 2 were significantly lower in the SILC group compared to LAC and HALC groups (*P* \< 0.05). On the other hand, in comparison between 16 single-port and 27 conventional laparoscopic right hemicolectomies of similar clinical background, Waters et al. concluded that no significant difference of short-term outcomes was observed between the 2 groups \[[@B37]\]. Adair et al., in their case-matched analysis of 17 single-port and multiport laparoscopic right colectomy cases, also found similar short-term outcomes between the 2 groups \[[@B38]\]. Wolthuis et al., in their case-matched study between SILC (*n* = 14) and LAC (*n* = 14) examining postoperative inflammatory response, reported that C-reactive protein (CRP) levels changed similarly in both groups (*P* = 0.34).

4. Discussion {#sec4}
=============

Potential advantages of SILC over other minimally invasive surgeries include a single small skin incision. The length of the skin incision is partly determined by the size of the resected specimen. Extraction difficulties may be encountered with large colon tumors or with obese patients with thick mesentery, omentum, or deep abdominal wall and colon filled with stool. In fact, our paper revealed that the final (at the end of operation) length of incision scar was longer than the initial one in all relevant reports, suggesting that cosmetic analysis on SILC should be based on final, not initial, scar length and objectively based on cosmesis scale or body image scale which has not yet been examined in any literature. In theory, a single midline fascial incision may minimizes trauma to the abdominal muscles, epigastric articles, and parietal nerves made by multiple trocars in LAC cases. This potentially leads to less postoperative pain and long-term additional port site complications; one out of two case-matched studies demonstrated significantly less postoperative pain score in SILC group as compared to LAC and HALS groups although another study failed to show less postoperative use of anesthesia in SILC group.

When introducing any new technology, one significant limitation is often the cost of the procedure. Generally, the initial increases in operative costs associated with laparoscopic techniques are mitigated by reduction in morbidity and duration of hospital stay as a result of the minimally invasive surgery. In fact, several studies which examined both short-term and long-term costs associated with laparoscopic colectomy showed an initial increase in the cost associated with laparoscopic colectomy but a long-term, overall saving. The potential challenge with SILC is that it will require purchase of proprietary instrumentation and additional equipments in some cases which increase overall operative cost. Although potential benefits including fewer conversions, a shorter postoperative recovery or LOS, and less morbidity would make SILC more cost effective, demonstration of any economic benefit over LAC can be difficult. Waters et al. \[[@B37]\] reported that the port itself was purchased at a cost of 550--650 USD compared with average cost of 80 USD of the ports used in the standard LAC cases. The marginal increase in direct operative cost was 310--410 USD per case. With similar operative time and LOS, it can be inferred that the total increase in cost is only that of the port device itself.

Concerning surgical instruments and techniques, SILS has several disadvantages compared with multiport laparoscopic surgery. Standard laparoscopic surgeries are performed through multiports allowing variation of scope placement and angling when met with obstructions. In SILS, no additional ports exist for placement of the scope and maneuvering is greatly restricted by nearby instruments. Therefore SILS requires an experienced surgeon to overcome the difficulties of triangulation, pneumoperitoneum leaks, and instrument crowding. In fact, according to our paper, as many as 9 cases needed to be converted to either open or multiports laparoscopic procedure to get better retraction or aid in colonic mobilization. Some investigators recommend utilizing articulating instruments or since obesity was found to be a common reason for conversion, variable length tools including a bariatric-length bowel grasper or an extra-long laparoscope to minimize external clashing are also recommended \[[@B21], [@B32]\]. One of the most challenging factors for SILC in attaining widespread use is the additional learning curve required for this technique. The SILC is essentially a one-operating surgeon technique which has a potentially detrimental impact upon resident education, affecting the training of future surgeons as well. Because most surgeons are still performing open colectomy (the prevalence of even standard LAC procedure is still under 25% in the US \[[@B44], [@B45]\]) or are on their own learning curve for laparoscopy, it requires further analysis to determine the impact that introducing a more technically demanding procedure has on training these surgeons.

5. Conclusions {#sec5}
==============

SILC is a challenging procedure but seems to be feasible and safe when performed by surgeons highly skilled in laparoscopy. SILC may have potential benefits over other types of minimally invasive surgeries (LAC or HALC), however this has not yet been objectively shown. In the future, randomized controlled trials with a large number of cases are necessary to determine the role of SILC in cost benefit, cosmetic, and oncologic outcomes.
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###### 

Characteristics of patients undergoing single-incision laparoscopic colorectal surgery.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author/year                                  No. of patients   Evidence level   Age        Gender (M/F)   ASA (I/II/III/IV)   Past surgical history (%)   BMI (kg/m^2^)   Indication
  -------------------------------------------- ----------------- ---------------- ---------- -------------- ------------------- --------------------------- --------------- ---------------------
  McNally et al. 2011 \[[@B21]\]               27                3                67^\#^\    13/14          0/16/9/0            44.4                        27^\#^          Malignant
                                                                                  (26--86)                                                                                  

                                                                                                                                                                            

  Bulut et al. 2011 \[[@B22]\]                 10                4                67^\#^\    2/8            3/6/1/0             60.0                        23.5^\#^\       Cancer
                                                                                  (49--83)                                                                  (20--25)        

                                                                                                                                                                            

  Gaujoux et al. 2011 \[[@B23]\]               13                4                53^\#^\    5/8            I/II: 13\           38.5                        23.5^\#^\       Polyp: 5\
                                                                                  (23--82)                  III/IV: 0                                       (18--30)        Crohn: 3\
                                                                                                                                                                            Diverticulitis: 3\
                                                                                                                                                                            Benign: 2

                                                                                                                                                                            

  Ramos-Valadez et al. 2011 \[[@B24]\]         20                3                59\        11/9           2^\#^               50.0                        25.9\           Benign: 17\
                                                                                  (37--76)                                                                  (20--33)        Malignant: 3

                                                                                                                                                                            

  Katsuno et al. 2011 \[[@B25]\]               31                4                67\        14/17          NA                  NA                          22.5            cancer
                                                                                  (58--79)                                                                                  

                                                                                                                                                                            

  Wolthuis et al. 2011 \[[@B26]\]              14                3                56^\#^\    5/9            0/12/2/0            NA                          22\             Crohn: 6\
                                                                                  (30--73)                                                                  (20--24)        Cancer: 3\
                                                                                                                                                                            Adenoma: 3\
                                                                                                                                                                            Diverticulitis: 2

                                                                                                                                                                            

  van den Boezem and Sietses 2011 \[[@B27]\]   50                4                65\        18/32          NA                  22.0                        27\             Malignant: 31\
                                                                                  (21--89)                                                                  (17--35)        Diverticulitis: 8\
                                                                                                                                                                            Polyp: 7\
                                                                                                                                                                            Colitis ulcerosa: 4

                                                                                                                                                                            

  Gash et al. 2011 \[[@B28]\]                  10                4                31^\#^\    4/6            NA                  30.0                        22^\#^\         UC
                                                                                  (21--56)                                                                  (20--28)        

                                                                                                                                                                            

  Champagne et al. 2011 \[[@B29]\]             29                2                61\        10/19          NA                  27.6                        27.4            Cancer: 12\
                                                                                  (25--93)                                                                                  Polyp: 4\
                                                                                                                                                                            Benign: 13

                                                                                                                                                                            

  Chew et al. 2011 \[[@B30]\]^\#^              21                4                63^\#^\    13/8           2^\#^               NA                          NA              Cancer: 14\
                                                                                  (48--63)                                                                                  Polyp: 4\
                                                                                                                                                                            Other: 3

                                                                                                                                                                            

  Chew et al. 2011 \[[@B30]\]^\#\#^            11                4                66^\#^\    5/6            2^\#^               NA                          NA              Cancer: 10\
                                                                                  (49--80)                                                                                  Polyp: 1

                                                                                                                                                                            

  Fichera et al. 2011 \[[@B31]\]               10                4                28\        8/2            NA                  NA                          21.9            UC: 10
                                                                                  (19--38)                                                                                  

                                                                                                                                                                            

  Chen et al. 2011 \[[@B32]\]                  18                3                69         10/8           I/II: 8\            NA                          23.3^\#^\       Cancer: 16\
                                                                                                            III/IV: 10                                      (18--29)        Diverticulosis: 2

                                                                                                                                                                            

  Papaconstantinou et al. 2011 \[[@B33]\]      29                3                60\        13/16          0/16/12/1           34.5                        30.0\           Cancer: 15\
                                                                                  (33--87)                                                                  (23--42)        Polyps: 12\
                                                                                                                                                                            Crohn: 2

                                                                                                                                                                            

  Ross et al. 2011 \[[@B34]\]                  39                4                58\        16/23          NA                  43.6                        25.6\           Cancer: 15\
                                                                                  (18--86)                                                                  (16--40)        Polyps: 12\
                                                                                                                                                                            Diverticulitis: 7\
                                                                                                                                                                            Crohn: 5

                                                                                                                                                                            

  Gandhi et al. 2010 \[[@B35]\]                24                3                54         12/12          2.3                 41.7                        28.5            Benign: 15\
                                                                                                                                                                            Malignant: 9

                                                                                                                                                                            

  Keshava et al. 2010 \[[@B36]\]               22                4                67^\#^\    11/11          NA                  NA                          27^\#^\         Cancer: 13\
                                                                                  (18--90)                                                                  (19--30)        Adenoma: 5\
                                                                                                                                                                            Other: 4

                                                                                                                                                                            

  Waters et al. 2010 \[[@B37]\]                16                3                65\        8/8            2.5                 43.8                        29\             Cancer: 10\
                                                                                  (39--82)                                                                  (20--41)        Other: 6

                                                                                                                                                                            

  Adair et al. 2010 \[[@B38]\]                 17                3                67         5/12           NA                  0^\#^                       26.2            Malignantcy: 11\
                                                                                                                                                                            Polyp: 4\
                                                                                                                                                                            Other: 2

                                                                                                                                                                            

  Gash et al. 2010 \[[@B39]\]                  20                4                46\        7/13           9/5/6/0             40.0                        25^\#^\         Cancer: 8\
                                                                                  (24--81)                                                                  (21--37)        Crohn: 4\
                                                                                                                                                                            UC: 3\
                                                                                                                                                                            Other: 5

                                                                                                                                                                            

  Vestweber et al. 2010 \[[@B40]\]             10                4                64^\#^     1/9            2^\#^               50.0                        26.7^\#^        Diverticulitis

                                                                                                                                                                            

  Boni et al. 2010 \[[@B41]\]                  36                4                69         NA             NA                  36.1                        NA              Malignant: 32\
                                                                                                                                                                            Polyp: 4
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^\#^data of right colectomies, ^\#\#^data of anterior resections, ASA: American Society of Anesthesiologist, BMI: body mass index, NA: data not available, UC: ulcerative colitis, SSI: surgical site infection, TME: total mesorectal excision, LAC: multiport laparoscopic colectomy, HALS: hand assisted laparoscopic surgery, UTI: urinary tract infection, ^\#^median value.

###### 

Perioperative parameters of single-incision laparoscopic colorectal surgery.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author/year                                  Colectomy                 Skin incision length (cm)   Operative time    Blood loss    Conversion         Additional port    Mortality    Morbidity              Reoperation                               
  -------------------------------------------- ------------------------- --------------------------- ----------------- ------------- ------------------ ------------------ ------------ ---------------------- ----------------------------------------- ---------------------------
  McNally et al. 2011 \[[@B21]\]               Right\                    NA                          NA\               114^\#^       50^\#^             18.5\              0            0                      18.5\                                     3.7\
                                               sigmoid\                                              (4--8)                                             (to LAC)                                               (ileus, arrhythmia, etc.)                 (cecal ischemia)
                                               transverse, and so on.                                                                                                                                                                                    

                                                                                                                                                                                                                                                         

  Bulut et al. 2011 \[[@B22]\]                 Low anterior\             2.5                         NA                229^\#^\      0^\#^\             0                  20.0         0                      20.0\                                     0\
                                               resection, and so on.                                                   (185--318)    (0--100)                                                                  (fluid collection, etc.)                  (two readmissions)

                                                                                                                                                                                                                                                         

  Gaujoux et al. 2011 \[[@B23]\]               Sigmoid\                  2.5                         3.2^\#^\          150^\#^\      0^\#^\             0                  0            0                      0                                         0
                                               right\                                                (2.5--5)          (100--240)    (0--350)                                                                                                            
                                               ileocolonic, and so on.                                                                                                                                                                                   

                                                                                                                                                                                                                                                         

  Ramos-Valadez et al. 2011 \[[@B24]\]         Sigmoid                   2.5 or 4                    3.3               159           58                 5.0\               0            0                      10.0\                                     0
                                                                                                                                                        (to LAC)                                               (wound complication)                      

                                                                                                                                                                                                                                                         

  Katsuno et al. 2011 \[[@B25]\]               Sigmoid\                  2.5--3                      2.7               156\          27\                0                  NA           0                      3.2\                                      NA
                                               right                                                                   (101--263)    (5--60)                                                                   (wound infection)                         

                                                                                                                                                                                                                                                         

  Wolthuis et al. 2011 \[[@B26]\]              Right\                    3.5^\#^                     5^\#^\            75^\#^\       0^\#^\             0                  0            0                      0                                         7.1\
                                               sigmoid                                               (4--6)            (70--105)     (0--20)                                                                                                             (negative relaparo-scopy)

                                                                                                                                                                                                                                                         

  van den Boezem and Sietses 2011 \[[@B27]\]   Right\                    3                           NA\               130           NA                 4.0\               4.0          0                      8.0\                                      2.0\
                                               sigmoid\                                              (−4.5)                                             (to LAC)                                               (wound infection)\                        (anastomotic leakage)
                                               low anterior\                                                                                                                                                   4.0 (hernia)\                             
                                               resection, and so on.                                                                                                                                           4.0 (ileus) 2.0 (leakage)                 

                                                                                                                                                                                                                                                         

  Gash et al. 2011 \[[@B28]\]                  Restorative\              2.5                         NA                185^\#^\      NA                 0                  0            0                      10.0 (surgical emphysema)\                NA
                                               proctocolectomy                                                         (100--381)                                                                              10.0 (panic attack)                       

                                                                                                                                                                                                                                                         

  Champagne et al. 2011 \[[@B29]\]             Right\                    2.5                         3.8               134           NA                 10.3\              6.9          0                      17.2 (ileus, etc.)                        0
                                               left                                                                                                     (to open/LAC)                                                                                    

                                                                                                                                                                                                                                                         

  Chew et al. 2011 \[[@B30]\]^\#^              Right                     2.5                         5^\#^\            85^\#^\       NA                 4.8\               0            0                      4.8\                                      0
                                                                                                     (3--10)           (45--150)                        (to LAC)                                               (arrhythmia)                              

                                                                                                                                                                                                                                                         

  Chew et al. 2011 \[[@B30]\]^\#\#^            Anterior resection        2.5                         5^\#^\            120^\#^\      NA                 36.4\              36.4         0                      18.2\                                     0
                                                                                                     (3--7)            (65--235)                        (to LAC)                                               (leakage, bleed)                          

                                                                                                                                                                                                                                                         

  Fichera et al. 2011 \[[@B31]\]               Total                     NA                          NA                139\          100\               0                  NA           0                      0                                         0
                                                                                                                       (110--180)    (20--400)                                                                                                           

                                                                                                                                                                                                                                                         

  Chen et al. 2011 \[[@B32]\]                  Right                     3                           4^\#^\            175^\#^\      75^\#^\            16.7\              NA           0                      16.6\                                     0
                                                                                                     (3--6)            (145--280)    (20--700)          (to open/LAC)                                          (ileus, wound infection, arrhythmia)      

                                                                                                                                                                                                                                                         

  Papaconstantinou et al. 2011 \[[@B33]\]      Right                     NA                          4.5\              129\          60\                3.4\               NA           0                      3.4 (leakage) 6.9 (SSI)\                  3.4\
                                                                                                     (2.5--7)          (53--187)     (20--150)          (to HALS)                                              10.3 (minor wound complication)           (anastomotic leakage)

                                                                                                                                                                                                                                                         

  Ross et al. 2011 \[[@B34]\]                  Right\                    NA                          4.2\              120\          67\                5.1\               7.7          0                      7.7\                                      0
                                               sigmoid\                                              (2.5--8)          (68--210)     (0--250)           (to open)                                              (wound infection, anastomotic bleeding)   
                                               ileocolic                                                                                                                                                                                                 

                                                                                                                                                                                                                                                         

  Gandhi et al. 2010 \[[@B35]\]                Right\                    2.5                         3.3\              143           63                 12.5\              NA           4.2\                   8.3\                                      0
                                               rectosigmoid                                          (2--6)                                             (to HALS/LAC)                   (metastatic disease)   (bleed, wound infection)                  

                                                                                                                                                                                                                                                         

  Keshava et al. 2010 \[[@B36]\]               Right                     3                           4^\#^\            105^\#^\      \<100 except two   0                  0            0                      27.3\                                     9.1\
                                                                                                     (3--6)            (85--140)                                                                               (ileus, bleed, wound hematoma)            (bleed, wound hematoma)

                                                                                                                                                                                                                                                         

  Waters et al. 2010 \[[@B37]\]                Right                     2                           (2.5--4.5)        106\          54\                0                  0            0                      18.8\                                     0
                                                                                                                       (71--223)     (25--120)                                                                 (wound infection, etc.)                   

                                                                                                                                                                                                                                                         

  Adair et al. 2010 \[[@B38]\]                 Right                     3                           3.8               139\          NA                 0                  11.8         5.9\                   29.4\                                     NA
                                                                                                                       (96--215)                                                        (pulmonary embolus)    (ileus, etc.)                             

                                                                                                                                                                                                                                                         

  Gash et al. 2010 \[[@B39]\]                  Right\                    2                           NA                110^\#^\      NA                 10.0\              0            0                      10.0 (ileus) 5.0 (wound infection)\       0\
                                               extended right\                                                         (45--240)                        (to LAC)                                               5.0 (bleed)\                              (one re-admission)
                                               anterior resection\                                                                                                                                             5.0 (hypertension)                        
                                               (TME), and so on.                                                                                                                                                                                         

                                                                                                                                                                                                                                                         

  Vestweber et al. 2010 \[[@B40]\]             Sigmoid                   2.5                         NA                120^\#^\      Minimal            10.0\              10.0         0                      10.0\                                     0
                                                                                                                       (79--156)                        (to open)                                              (subcutaneous hematoma)                   

                                                                                                                                                                                                                                                         

  Boni et al. 2010 \[[@B41]\]                  Right                     3--3.5                      2.6^a^\           145\          NA                 0                  NA           0                      5.6\                                      0
                                                                                                     (2.1--3.1)        (110--172)                                                                              (UTI, ileus)                              
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^\#^data of right colectomies, ^\#\#^data of anterior resections, BMI: body mass index, NA: data not available, UC: ulcerative colitis, SSI: surgical site infection, TME: total mesorectal excision, LAC: multiport laparoscopic colectomy, HALS: hand assisted laparoscopic surgery, UTI: urinary tact infection, ^\#^median value, ^a^measured on postoperative day 10.

###### 

Required materials of single-incision laparoscopic colorectal surgery.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                                       Patient\'s position           Port system                    Laparoscope                                              
  -------------------------------------------- ----------------------------- ------------------------------ --------------------------- ---------- --------- ------- ------------------------------------------------------
  McNally et al. 2011 \[[@B21]\]               NA                            SILS port, Gelport, SSL port   NA                          NA         NA        NA      NA

                                                                                                                                                                     

  Bulut et al. 2011 \[[@B22]\]                 Lloyd-Davis                   SILS port                      3 trocars (5, 5, 5)         Straight   5         0^°^    5 mm curved endoscopic grasper

                                                                                                                                                                     

  Gaujoux et al. 2011 \[[@B23]\]               Modified lithotomy            SILS port                      3 trocars (5, 5, 5)         NA         5         0^°^    Standard grasper

                                                                                                                                                                     

  Ramos-Valadez et al. 2011 \[[@B24]\]         Modified lithotomy            SILS port, GelPOINT\           3 trocars (5, 5, 5)         NA         5         30^°^   Standard nonarticulated laparoscopic instrumentation
                                                                             Gelport                                                                                 

                                                                                                                                                                     

  Katsuno et al. 2011 \[[@B25]\]               Lithotomy                     Trocar insertion\              3 trocars (5, 5, 5 or 12)   Rigid      5         30^°^   NA
                                                                             method, SILS port                                                                       

                                                                                                                                                                     

  Wolthuis et al. 2011 \[[@B26]\]              Supine\                       SILS port, Quard Port\         3 trocars (5, 5, 5)         NA         5         30^°^   Endo grasp
                                               (right hemicolectomy)\        GelPOINT, SSL access system                                                             
                                               Modified Lloyd-Davies\                                                                                                
                                               (sigmoid resection)                                                                                                   

                                                                                                                                                                     

  van den Boezem and Sietses 2011 \[[@B27]\]   Supine\                       SILS port                      3 trocars (5, 5, 12)        Standard   10        30^°^   Straight atraumatic grasper
                                               (right hemicolectomy)\                                                                                                
                                               Lithotomy\                                                                                                            
                                               (sigmoid resection)                                                                                                   

                                                                                                                                                                     

  Gash et al. 2011 \[[@B28]\]                  Dorsolithotomy                SILS port, TriPort             3 trocars (5, 5, 12)        NA         5 or 10   30^°^   NA

                                                                                                                                                                     

  Champagne et al. 2011 \[[@B29]\]             NA                            SILS port                      3 trocars (NA)              NA         NA        NA      NA

                                                                                                                                                                     

  Chew et al. 2011 \[[@B30]\]                  Supine\                       SILS port, SSL access\         3 trocars (5, 5, 12)        NA         NA        NA      NA
                                               (rectum: lithotomy)           system, TriPort                                                                         

                                                                                                                                                                     

  Fichera et al. 2011 \[[@B31]\]               Lithotomy                     Gelport                        4 trocars (5, 5, 5, 12)     Rigid      5         30^°^   NA

                                                                                                                                                                     

  Chen et al. 2011 \[[@B32]\]                  NA                            None^\#^                       3 trocars (5, 5, 5)         Rigid      5         30^°^   NA

                                                                                                                                                                     

  Papaconstantinou et al. 2011 \[[@B33]\]      NA                            SILS port                      NA                          NA         NA        NA      NA

                                                                                                                                                                     

  Ross et al. 2011 \[[@B34]\]                  Supine                        GelPOINT                       3 trocars (5, 5, 12)        NA         NA        30^°^   NA

                                                                                                                                                                     

  Gandhi et al. 2010 \[[@B35]\]                Supine\                       SILS port, GelPOINT\           3 trocars (5, 5, 5)         NA         5         30^°^   NA
                                               (rectum: lithotomy)           Gelport                                                                                 

                                                                                                                                                                     

  Keshava et al. 2010 \[[@B36]\]               Modified Lloyd Davies         Gelport                        4 trocars (5, 5, 12, 12)    NA         10        30^°^   NA

                                                                                                                                                                     

  Waters et al. 2010 \[[@B37]\]                NA                            SILS port                      3 trocars (5, 5, 5)         Rigid      5         30^°^   NA

                                                                                                                                                                     

  Adair et al. 2010 \[[@B38]\]                 Low lithotomy                 SILS port, GelPOINT\           3 trocars (NA)              Flexible   5         NA      NA
                                                                             Gelport, TriPort                                                                        

                                                                                                                                                                     

  Gash et al. 2010 \[[@B39]\]                  NA                            TriPort                        3 trocars (5, 5, 12)        NA         5 or 10   30^°^   Johan bowel grasper

                                                                                                                                                                     

  Vestweber et al. 2010 \[[@B40]\]             Supine, steep Trendelenburg   SILS port                      3 trocars (NA)              NA         5         30^°^   NA

                                                                                                                                                                     

  Boni et al. \[[@B40]\]                       Supine, left side down,\      SILS port\                     3 trocars (NA)              NA         NA        NA      Articulating endograsper
                                               and mild Trendelenberg        Endocone                                                                                
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

NA: data not available, ^\#^surgical glove.

###### 

Postoperative recovery of single-incision laparoscopic colectomy.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                                  Length of specimen      Margins   Dissected lymph nodes   Postoperative analgesia             Time to flatus/bowel movement   Start regular diet     Hospital stay
  --------------------------------------- ----------------------- --------- ----------------------- ----------------------------------- ------------------------------- ---------------------- ---------------------
  McNally et al. \[[@B21]\]               NA                      0         15^\#^ (3--32)          NA                                  NA                              NA                     3^\#^ (2--17)

                                                                                                                                                                                               

  Bulut et al. \[[@B22]\]                 15.3\                   0         14^\#^ (3--20)          NA                                  NA                              NA                     7^\#^ (4--14)
                                          (10--32)                                                                                                                                             

                                                                                                                                                                                               

  Gaujoux et al. \[[@B23]\]               NA                      NA        NA                      NA                                  (2-3)                           1                      6^\#^ (4--10)

                                                                                                                                                                                               

  Ramos-Valadez et al. \[[@B24]\]         NA                      0         20\                     NA                                  NA                              NA                     3.2
                                                                            in malignant cases                                                                                                 

                                                                                                                                                                                               

  Katsuno et al. \[[@B25]\]               NA                      0         18                      1.4 ± 1.2\                          NA                              1.5 + 0.8              9.2
                                                                                                    analgesics times                                                                           

                                                                                                                                                                                               

  Wolthuis et al. \[[@B26]\]              17^\#^ (16--23)         0         12^\#^ (8--17)          Total 313 mg (198--650 mg)\         NA                              NA                     7^\#^ (5--9)
                                                                                                    (levobupivacaine)\                                                                         
                                                                                                    total 250 *μ*g (158--520 *μ*g)\                                                            
                                                                                                    (sufentanyl)                                                                               

                                                                                                                                                                                               

  van den Boezem and Sietses \[[@B27]\]   NA                      0         14 (10-)                NA                                  NA                              NA                     6^\#^ (3--30)

                                                                                                                                                                                               

  Gash et al. \[[@B28]\]                  NA                      NA        NA                      NA                                  NA                              36 h^\#^ (4--48 h)     3^\#^ (2--8)

                                                                                                                                                                                               

  Champagne et al. \[[@B29]\]             43.5                    0         19.4\                   NA                                  NA                              NA                     3.7
                                                                            in malignant cases                                                                                                 

                                                                                                                                                                                               

  Chew et al. \[[@B30]\]\                 18.5^\#^ (10.5--34.0)   0         17^\#^ (10--30)\        NA                                  NA                              NA                     6^\#^ (5--11)
  (right hemicolectomy)                                                     in malignant cases                                                                                                 

                                                                                                                                                                                               

  Chew et al. 2011 \[[@B30]\]\            15.0^\#^ (11.0--38.0)   0         14^\#^ (6--16)\         NA                                  NA                              NA                     6^\#^ (5--21)
  (anterior resection)                                                      in malignant cases                                                                                                 

                                                                                                                                                                                               

  Fichera et al. \[[@B31]\]               NA                      NA        NA                      NA                                  1.6 (1--3)\                     3 (2--4)               5.1 (4--7)
                                                                                                                                        ostomy\                                                
                                                                                                                                        output                                                 

                                                                                                                                                                                               

  Chen et al. \[[@B32]\]                  NA                      0         19.5^\#^ (3--42)\       NA\                                 2^\#^ (1--7)                    NA                     5^\#^ (3--15)
                                                                            in malignant cases      10^\#^ (0--60)                                                                             

  (Demerol equivalents (mg))                                                                                                                                                                   

                                                                                                                                                                                               

  Papaconstantinou et al. \[[@B33]\]      NA                      NA        16.4 (4--38)            NA                                  NA                              NA                     3.4 (1--8)

                                                                                                                                                                                               

  Ross et al. \[[@B34]\]                  NA                      0         19 (12--39)\            NA                                  2.2 (1--4)\                     NA                     4.4 (2--8)
                                                                            in malignant cases                                          2.9 (1--6)                                             

                                                                                                                                                                                               

  Gandhi et al. \[[@B35]\]                NA                      NA        24.6\                   NA                                  NA                              NA                     2.7
                                                                            in malignant cases                                                                                                 

                                                                                                                                                                                               

  Keshava et al. \[[@B36]\]               NA                      0         17^\#^ (10--23)         NA                                  NA                              NA                     5^\#^ (3--35)

                                                                                                                                                                                               

  Waters et al. \[[@B37]\]                18 (14--35)             0         18 (13--22)             NA                                  NA                              NA                     5 (2--24)

                                                                                                                                                                                               

  Adair et al. \[[@B38]\]                 NA                      NA        20 (12--39)             NA                                  NA                              NA                     3.9 + 3.7 (1--18)

                                                                                                                                                                                               

  Gash et al. \[[@B39]\]                  NA                      NA        NA                      NA\                                 NA                              4--6 h \[7cases\]\     46 h^\#^ (8--384 h)
                                                                                                    (TAP blocks)                                                        12--16 h \[11cases\]   

                                                                                                                                                                                               

  Vestweber et al. \[[@B40]\]             18.5 (15--22)           NA        NA                      NA                                  NA                              NA                     7^\#^ (6--15)

                                                                                                                                                                                               

  Boni et al. \[[@B41]\]                  NA                      0         24 (15--29)             NA\                                 NA                              2                      5 (4--14)
                                                                                                    (regular IV paracetamol infusion)                                                          
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

NA: data not available, TAP: transvers abdominis plane, ^\#^median value.

###### 

Comparison of intraoperative parameters between single-incision laparoscopic colectomy and other minimally invasive surgeries.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                               Study type        No. of patients                 Incision length                         Operative time                        Blood loss                            Conversion (%)
  ------------------------------------ ----------------- ------------------------------- --------------------------------------- ------------------------------------- ------------------------------------- ------------------------------
  McNally et al. \[[@B21]\]            No case matched   27 versus 46\                   NA                                      114^\#^ versus 135^\#^\               50^\#^ versus 50^\#^\                 0 versus 13.0\
                                                         (SILC versus LAC)                                                       (*P* = 0.08)                          (*P* = 0.21)                          (*P* = NA)

                                                                                                                                                                                                             

  Ramos-Valadez et al. \[[@B24]\]      Case matched      20 versus 20\                   3.3 versus 3.2\                         159 versus 162\                       58 versus 99\                         0 versus 0
                                                         (SILC versus LAC)               (*P* \< 0.70)                           (*P* \< 0.80)                         **(** ***P***   **\<**   **0.007)**   

                                                                                                                                                                                                             

  Wolthuis et al. \[[@B26]\]           Case matched      14 versus 14\                   5^\#^ versus 5^\#^\                     75^\#^ versus 83^\#^\                 0^\#^ versus 10^\#^\                  0 versus 0
                                                         (SILC versus LAC)               (*P* = 0.81)                            (*P* = 0.31)                          (*P* = 0.99)                          

                                                                                                                                                                                                             

  Champagne et al. \[[@B29]\]          Case matched      29 versus 29\                   3.8 versus 4.5\                         134 versus 104\                       NA                                    17.2 versus 6.9\
                                                         (SILC versus LAC)               (*P* = 0.098)                           **(** ***P***   **=**   **0.0002)**                                         (*P* = 0.11)

                                                                                                                                                                                                             

  Chen et al. \[[@B32]\]               Case matched      18 versus 21\                   4^\#^ versus 4^\#^\                     175^\#^ versus 165^\#^\               75^\#^ versus 50^\#^\                 16.7 versus 0\
                                                         (SILC versus LAC)               (*P* = 0.52)                            (*P* = 0.16)                          (*P* = 0.67)                          (*P* = 0.052)

                                                                                                                                                                                                             

  Papaconstantinou et al. \[[@B33]\]   Case matched      29 versus 29 versus 29\         4.5 versus 5.1 versus 7.1\              129 versus 128 versus 116\            60 versus 90 versus 71\               3.4 versus 13.8 versus 13.8\
                                                         (SILC versus LAC versus HALS)   **(** ***P***  **\<**   **0.05)**       (*P* = 0.27)                          (*P* = 0.19)                          (*P* = 0.20)

                                                                                                                                                                                                             

  Gandhi et al. \[[@B35]\]             Case matched      24 versus 24\                   3.3 versus 6.6\                         143 versus 113\                       63 versus 91\                         12.5 versus 0\
                                                         (SILC versus HALS)              **(** ***P***   **\<**   **0.00001)**   (***P***   **=**   **0.0004**)        (*P* = 0.06)                          (*P* = 0.083)

                                                                                                                                                                                                             

  Waters et al. \[[@B37]\]             No case matched   16 versus 27\                   NA                                      106 versus 100\                       54 versus 90\                         0 versus 0
                                                         (SILC versus LAC)                                                       (*P* = 0.64)                          (*P* = 0.07)                          

                                                                                                                                                                                                             

  Adair et al. \[[@B38]\]              Case matched      17 versus 17\                   3.8 versus 5.1\                         139 versus 134\                       NA                                    NA
                                                         (SILC versus LAC)               (extraction port size)                  (*P* = 0.61)                                                                
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

NA: data not available, SILC: single-incision laparoscopic colectomy, LAC: multiport laparoscopic colectomy, HALS: hand-assisted laparoscopic surgery (colectomy), ^\#^median value.

###### 

Comparison of pathological and surgical outcomes between single-incision laparoscopic colectomy and other minimally invasive surgeries.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                               No. of patients                  Margin                                    Dissected lymph nodes            Length of specimen      Mortality             Morbidity                              Readmission                    Hospital stay                    Postoperative pain score
  ------------------------------------ -------------------------------- ----------------------------------------- -------------------------------- ----------------------- --------------------- -------------------------------------- ------------------------------ -------------------------------- -----------------------------------
  McNally et al. \[[@B21]\]            27 versus 46\                    0 versus 0                                15^\#^ versus 17^\#^\            NA                      0 versus 4.3\         18.5 versus 34.8\                      NA                             3^\#^ versus 5^\#^\              NA
                                       (SILC versus LAC)                                                          (*P* = 0.33)                                             (*P* = NA)            (*P*= NA)                                                             (*P* = 0.07)                     

                                                                                                                                                                                                                                                                                                        

  Ramos-Valadez et al. \[[@B24]\]      20 versus 20 (SILC versus LAC)   0 versus 0                                20.3 versus 18.3 (*P* \< 0.68)   NA                      0 versus 0            10.0 versus 10.0 (*P* \< 1.0)          0 versus 0                     3.2 versus 3.8 (*P* \< 0.25)     NA

                                                                                                                                                                                                                                                                                                        

  Wolthuis et al. \[[@B26]\]           14 versus 14\                    0 versus 0                                12^\#^ versus 14^\#^\            17^\#^ versus 18^\#^\   0 versus 0            0 versus 0                             0 versus 0                     7^\#^ versus 6^\#^\              Overall mean1.00 versus 1.39\
                                       (SILC versus LAC)                                                          (*P* = NA)                       (*P* = 0.47)                                                                                                        (*P* = 0.13)                     (*P* = 0.25)

                                                                                                                                                                                                                                                                                                        

  Champagne et al. \[[@B29]\]          29 versus 29\                    0 versus 0                                19.4 versus 21.6\                44 versus 44\           NA                    17.2 versus 24.1\                      NA                             3.7 versus 3.9\                  NA
                                       (SILC versus LAC)                                                          (*P* = 0.81)                     (*P* = 0.54)                                  (*P* = 0.28)                                                          (*P* = 0.44)                     

                                                                                                                                                                                                                                                                                                        

  Chen et al. \[[@B32]\]               18 versus 21\                    Distal free margin (cm) 16 versus 13.5\   19.5^\#^ versus 19^\#^\          NA                      0 versus 0            16.6 versus 9.5\                       0 versus 0                     5^\#^ versus 5^\#^\              Demerol usage (mg)\
                                       (SILC versus LAC)                (*P* = 0.094)                             (*P* = 0.98)                                                                   (*P* = 0.51)                                                          (*P* = 0.90)                     10^\#^ versus 10^\#^\
                                                                                                                                                                                                                                                                                                        (*P* = 0.82)

                                                                                                                                                                                                                                                                                                        

  Papaconstantinou et al. \[[@B33]\]   29 versus 29 versus 29\          NA                                        16.4 versus 16.9 versus 18.1\    NA                      0 versus 0 versus 0   \(i\) Leakage 3.4 versus 0 versus 0\   13.8 versus 6.9 versus 10.3\   3.4 versus 4.6 versus 4.9\       Mean maximum\
                                       (SILC versus LAC versus HALS)                                              (*P* = 0.83)                                                                   (*P* = 0.36)\                          (*P* = 0.69)                   **(** ***P*** **\<** **0.05)**   Day 1: 4.7 versus 6.0 versus 6.0\
                                                                                                                                                                                                 (ii) SSI\                                                                                              **(** ***P*** **\<** **0.05)**\
                                                                                                                                                                                                 6.9 versus 10.3 versus 6.9\                                                                            Day 2: 3.8 versus 5.2 versus 5.0\
                                                                                                                                                                                                 (*P* = 0.86)\                                                                                          **(** ***P*** **\<** **0.05)**
                                                                                                                                                                                                 (iii) Minor wound complication\                                                                        
                                                                                                                                                                                                 10.3 versus 13.8 versus 17.2\                                                                          
                                                                                                                                                                                                 (*P* = 0.75)                                                                                           

                                                                                                                                                                                                                                                                                                        

  Gandhi et al. \[[@B35]\]             24 versus 24\                    NA                                        24.6 versus 18.6\                NA                      NA                    8.3 versus 0\                          NA                             2.7 versus 3.3\                  NA
                                       (SILC versus HALS)                                                         (*P* = 0.22)                                                                   (*P* = 0.15)                                                          **(** ***P*** **=** **0.02)**    

                                                                                                                                                                                                                                                                                                        

  Waters et al. \[[@B37]\]             16 versus 27\                    0 versus 0                                18 versus 16\                    18 versus 18\           0 versus 3.7\         18.8 versus 14.8\                      6.3 versus 3.7\                5 versus 6\                      NA
                                       (SILC versus LAC)                                                          (*P* = 0.10)                     (*P* = 0.92)            (*P* = 0.44)          (*P* = 0.99)                           (*P* = 0.99)                   (*P* = 0.53)                     

                                                                                                                                                                                                                                                                                                        

  Adair et al. \[[@B38]\]              17 versus 17\                    NA                                        20.1 versus 18.6\                NA                      5.9 versus 0\         29.4 versus 23.5\                      NA                             3.9 versus 4.1\                  NA
                                       (SILC versus LAC)                                                          (*P* = 0.70)                                             (*P* = NA)            (*P* = NA)                                                            (*P* = 0.87)                     
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

NA: data not available, SILC: single-incision laparoscopic colectomy, LAC: multiport laparoscopic colectomy, HALS: hand-assisted laparoscopic surgery (colectomy).

^\#^Median value, SSI: surgical site infection.
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